Searched for
JUBILANT HOLLISTERSTIER
Jubilant Pharmova arm to invest $300 mn in US by FY28 to double sterile injectable capacityJubilant HollisterStier LLC is investing USD 300 million by FY28 to double its sterile injectable manufacturing capacity in the US. The com...- Stocks in news: HDFC Bank, Vodafone Idea, Dr Reddy's, RIL, IndiGoStocks in news: Domestic markets continued their rebound, gaining nearly half a percent on Tuesday, driven by a recovery in global indices....
- Jubilant Life gets nod for Sodium Chloride injection“This is the first ANDA approval in injectables received by the company. We have filed two injectables and one ophthalmic product as on Mar...
- US FDA upgrades Jubilant Life's US plant statusThe company currently has 10 manufacturing facilities in India, the US and Canada with 6,200 as global headcount.
- Jubilant Life Sciences gets warning letter from USFDAJLL received a warning letter from the USFDA over violation of manufacturing norms at one of its plants located in Washington state.
- Jubilant Life Sciences plunges 10% on USFDA warning letterJubilant Life Sciences was witnessing selling pressure after one of its manufacturing facilities in the US, was issued a warning letter (WL...
- Jubilant Life scrip down 5%; valuation erodes by Rs 146 croreShares of Jubilant Life Sciences fell 5 per cent after the US health regulator issued a warning letter for violation of manufacturing norms...
- Jubilant Life bags $90 million contract for parenteral productsJubilant Life Sciences today said it has secured contracts worth more than $90 million (over Rs 440 crore) from four life sciences firms.
- Jubilant Life inks $70-m deal with US drugmaker for over-the-counter women healthcare productsThe company's American subsidiary, Jubilant HollisterStier, has begun production of the drug at its Montreal facility.
- Jubilant inks $70 mn manufacturing pact with US firmJubilant Life Sciences today said its has signed a contract manufacturing agreement with an undisclosed US pharmaceutical firm to produce a...
- Religare assigns 'buy' to Jubilant on Draxis buy; target Rs 405The acquisition of Canada-based Draxis Health is expected to enhance Jubilant Organosys’ presence in the regulated markets of North America...
- Jubilant set to buy Draxis for Rs 1,020 crThis is the Delhi company's sixth buy and its first in Canada. Last year, it acquired Hollister Stier in the US for $125 million.
- Jubilant hunts for buys abroadJubilant Organosys is evaluating various proposals to acquire companies in the contract research and manufacturing services (CRAMS), drug d...
- Jubilant acquires Hollister for Rs 502 crThe acquisition will augment the Indian firm's grip on custom research & manufacturing service biz globally.
- Jubilant to buy US co for $123mJubilant Organosys is acquiring US-based contract research and manufacturing services (CRAMS) company Hollister-Stier Labora-tories LLC for...
Load More
